CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Biologics (BLA & Biosimilars)
Original article

WILATE

WILATENeutral
AI Analysis

Summary

WILATE is indicated in adults and adolescents with hemophilia A for routine prophylaxis to reduce bleeding episodes and for on-demand treatment and control of bleeding episodes.

Importance:1/10
Sentiment:
0.00
hemophilia Aprophylaxisbleeding disorder
Related Companies

Read the original article

Published by FDA Biologics (BLA & Biosimilars) on July 23, 2026 5:32 PM

Read Original